Tammy W Shen1, Catherine A Fromen2, Marc P Kai2, J Christopher Luft1, Tojan B Rahhal1, Gregory R Robbins3, Joseph M DeSimone4,5,6,7. 1. Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. 2. Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695, USA. 3. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. 4. Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. desimone@unc.edu. 5. Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, 27695, USA. desimone@unc.edu. 6. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. desimone@unc.edu. 7. Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA. desimone@unc.edu.
Abstract
PURPOSE: We evaluated the role of a poly(ethylene glycol) (PEG) surface coating to increase residence times and alter the cellular fate of nano- and microparticles delivered to the lung. METHODS: Three sizes of PRINT hydrogel particles (80 × 320 nm, 1.5 and 6 μm donuts) with and without a surface PEG coating were instilled in the airways of C57/b6 mice. At time points of 1, 7, and 28 days, BALF and whole lungs were evaluated for the inflammatory cytokine Il-6 and chemokine MIP-2, histopathology, cellular populations of macrophages, dendritic cells (DCs), and granulocytes, and particulate uptake within these cells through flow cytometry, ELISAs, and fluorescent imaging. RESULTS: Particles of all sizes and surface chemistries were readily observed in the lung with minimal inflammatory response at all time points. Surface modification with PEGylation was found to significantly increase lung residence times and homogeneous lung distribution, delaying macrophage clearance of all sizes, with the largest increase in residence time observed for 80 × 320 nm particles. Additionally, it was observed that DCs were recruited to the airway following administration of unPEGylated particles and preferentially associated with these particles. CONCLUSIONS: Pulmonary drug delivery vehicles designed with a PEG surface coating can be used to delay particle uptake and promote cell-specific targeting of therapeutics.
PURPOSE: We evaluated the role of a poly(ethylene glycol) (PEG) surface coating to increase residence times and alter the cellular fate of nano- and microparticles delivered to the lung. METHODS: Three sizes of PRINT hydrogel particles (80 × 320 nm, 1.5 and 6 μm donuts) with and without a surface PEG coating were instilled in the airways of C57/b6 mice. At time points of 1, 7, and 28 days, BALF and whole lungs were evaluated for the inflammatory cytokine Il-6 and chemokine MIP-2, histopathology, cellular populations of macrophages, dendritic cells (DCs), and granulocytes, and particulate uptake within these cells through flow cytometry, ELISAs, and fluorescent imaging. RESULTS: Particles of all sizes and surface chemistries were readily observed in the lung with minimal inflammatory response at all time points. Surface modification with PEGylation was found to significantly increase lung residence times and homogeneous lung distribution, delaying macrophage clearance of all sizes, with the largest increase in residence time observed for 80 × 320 nm particles. Additionally, it was observed that DCs were recruited to the airway following administration of unPEGylated particles and preferentially associated with these particles. CONCLUSIONS: Pulmonary drug delivery vehicles designed with a PEG surface coating can be used to delay particle uptake and promote cell-specific targeting of therapeutics.
Entities:
Keywords:
Microparticle; Nanoparticle; PEGylation; Pulmonary drug delivery
Authors: Jung Soo Suk; Anthony J Kim; Kanika Trehan; Craig S Schneider; Liudmila Cebotaru; Owen M Woodward; Nicholas J Boylan; Michael P Boyle; Samuel K Lai; William B Guggino; Justin Hanes Journal: J Control Release Date: 2014-01-14 Impact factor: 9.776
Authors: S Salvi; A Blomberg; B Rudell; F Kelly; T Sandström; S T Holgate; A Frew Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Luis E Muñoz; Rostyslav Bilyy; Mona H C Biermann; Deborah Kienhöfer; Christian Maueröder; Jonas Hahn; Jan M Brauner; Daniela Weidner; Jin Chen; Marina Scharin-Mehlmann; Christina Janko; Ralf P Friedrich; Dirk Mielenz; Tetiana Dumych; Maxim D Lootsik; Christine Schauer; Georg Schett; Markus Hoffmann; Yi Zhao; Martin Herrmann Journal: Proc Natl Acad Sci U S A Date: 2016-09-19 Impact factor: 11.205
Authors: Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2016-03-25
Authors: Jillian L Perry; Shaomin Tian; Nisitha Sengottuvel; Emily B Harrison; Balachandra K Gorentla; Chintan H Kapadia; Ning Cheng; J Christopher Luft; Jenny P-Y Ting; Joseph M DeSimone; Chad V Pecot Journal: ACS Nano Date: 2020-06-02 Impact factor: 15.881
Authors: Bader M Jarai; Zachary Stillman; Lucas Attia; Gerald E Decker; Eric D Bloch; Catherine A Fromen Journal: ACS Appl Mater Interfaces Date: 2020-08-20 Impact factor: 9.229
Authors: Catherine A Fromen; William J Kelley; Margaret B Fish; Reheman Adili; Jeffery Noble; Mark J Hoenerhoff; Michael Holinstat; Omolola Eniola-Adefeso Journal: ACS Nano Date: 2017-10-19 Impact factor: 15.881
Authors: Catherine A Fromen; Tojan B Rahhal; Gregory R Robbins; Marc P Kai; Tammy W Shen; J Christopher Luft; Joseph M DeSimone Journal: Nanomedicine Date: 2015-12-01 Impact factor: 5.307